IGC PHARMA, INC. Foreign Income Tax Expense (Benefit), Continuing Operations
IGC PHARMA, INC. (IGC) reported Foreign Income Tax Expense (Benefit), Continuing Operations of $0 for the 12-month period ending 2019-03-31, per its 10-K filed 2019-06-14.
Discontinued › Expense Statement › Income Tax
us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations · last filed 2019-06-14
- IGC PHARMA, INC. foreign income tax expense (benefit), continuing operations for the quarter ending 2013-12-31 was $1.89K.
- IGC PHARMA, INC. foreign income tax expense (benefit), continuing operations for the quarter ending 2013-09-30 was $1.51K.
- IGC PHARMA, INC. foreign income tax expense (benefit), continuing operations for the quarter ending 2013-06-30 was $1.60K.
- IGC PHARMA, INC. foreign income tax expense (benefit), continuing operations for the quarter ending 2012-12-31 was -$453.00.
- IGC PHARMA, INC. foreign income tax expense (benefit), continuing operations for fiscal 2019 was $0.00.
- IGC PHARMA, INC. foreign income tax expense (benefit), continuing operations for fiscal 2018 was $0.00.
- IGC PHARMA, INC. foreign income tax expense (benefit), continuing operations for fiscal 2017 was $0.00.
- IGC PHARMA, INC. foreign income tax expense (benefit), continuing operations for fiscal 2016 was $0.00.
| Period end | Foreign Income Tax Expense (Benefit), Continuing Operations 3 month | Foreign Income Tax Expense (Benefit), Continuing Operations 6 month | Foreign Income Tax Expense (Benefit), Continuing Operations 9 month | Foreign Income Tax Expense (Benefit), Continuing Operations 12 month |
|---|---|---|---|---|
| 2019-03-31 | $0.00 10-K · filed 2019-06-14 | |||
| 2018-03-31 | $0.00 10-K · filed 2019-06-14 | |||
| 2017-03-31 | $0.00 10-K · filed 2018-06-21 | |||
| 2016-03-31 | $0.00 10-K · filed 2017-07-14 | |||
| 2015-03-31 | $0.00 10-K · filed 2016-07-14 | |||
| 2014-03-31 | $0.00 10-K · filed 2015-07-14 | |||
| 2013-12-31 | $1.89K 10-Q · filed 2014-02-14 | $3.39K derived: sum of 2 quarters · filed 2014-02-14 | $4.99K derived: sum of 3 quarters · filed 2014-02-14 | |
| 2013-09-30 | $1.51K 10-Q · filed 2013-11-08 | $3.10K derived: sum of 2 quarters · filed 2013-11-08 | ||
| 2013-06-30 | $1.60K 10-Q · filed 2013-08-16 | |||
| 2013-03-31 | $0.00 10-K · filed 2013-07-16 | |||
| 2012-12-31 | -$453.00 10-Q · filed 2014-02-14 | -$10.19K derived: sum of 2 quarters · filed 2014-02-14 | -$41.90K derived: sum of 3 quarters · filed 2014-02-14 | |
| 2012-09-30 | -$9.73K 10-Q · filed 2013-11-08 | -$41.45K derived: sum of 2 quarters · filed 2013-11-08 | ||
| 2012-06-30 | -$31.71K 10-Q · filed 2013-08-16 | |||
| 2012-03-31 | $0.00 10-K · filed 2013-07-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |